Heavyweights

Sean Parker reflection

Heavyweights

Billionaire Sean Parker is nerding out on cancer research. Science has never seen anyone quite like him

By Rebecca Robbins

Al Sandrock Biogen

Exclusive

One of the world’s best drug hunters went after Alzheimer’s. Here’s how he lost

By Matthew Herper

Dr. Nils Lonberg

Heavyweights

The entrepreneur behind the cancer immunotherapy revolution

By Matthew Herper

Sean Parker

Heavyweights

Billionaire Sean Parker calls China’s gene-edited babies ‘Sputnik 2.0,’ praises FDA, and offers career advice for millennials

American geneticist James Dewey Watson in 1993.

Heavyweights

‘I really don’t know what happened to Jim’: Friends ask where James Watson’s odious attitudes about race came from

By Sharon Begley

Elijah Cummings

Heavyweights

Elijah Cummings sparred with Martin Shkreli and Mylan’s CEO. Now he’s got a gavel to take on pharma

By Andrew Joseph

Padmanee Sharma

Heavyweights

A pioneer in cancer immunotherapy sees a future where vaccines, CAR-T, and checkpoint inhibitors come together

By Sharon Begley

Exclusive

Out of prison, the ‘father of gene therapy’ faces a harsh reality: a tarnished legacy and an ankle monitor

By Sharon Begley

Heavyweights

How Pfizer’s CEO flew under the political radar with price hikes — until he tangled with Trump

By Ed Silverman and Kate Sheridan

Dr. Alice Flaherty 02

Heavyweights

It’s not ‘all in your head’: When other doctors give up on patients, a boundary-breaking neurologist treats them

By Eric Boodman

Laura Deming

Heavyweights

Her bio reads like Silicon Valley fan fiction. At 23, she’s investing millions in the quest to defy death

By Rob Waters

Michael Eisen

Heavyweights

He takes on Eric Lander, and the scientific establishment. ‘This is who I am. I get angry.’

By Andrew Joseph

Magdalena Skipper

Heavyweights

Meet Nature’s new editor: a geneticist who reads scientific papers like ‘page turners’

By Megan Thielking

CJ Peters

Heavyweights

The virus hunter: In a bygone era, C.J. Peters learned how to bend the rules

By Helen Branswell

Pablo Ross

Heavyweights

Near the campus cow pasture, a scientist works to grow human organs — in pigs

By Usha Lee McFarling

Paul J. Hanly

Heavyweights

A veteran New York litigator is taking on opioid makers. They have a history

By Andrew Joseph

Dr. Feng Zhang

Heavyweights

Not just for CRISPR: Lemelson-MIT Prize honors Feng Zhang for ‘big ideas that change fields’

By Sharon Begley

Vinay K. Prasad

Heavyweights

Did he really just tweet that? Dr. Vinay Prasad takes on Big Pharma, Big Medicine, and his own colleagues — with glee

By Meghana Keshavan

Juan Carkos Belmonte

Heavyweights

The creator of the pig-human chimera keeps proving other scientists wrong

By Usha Lee McFarling

DR. JEN GUNTER

Heavyweights

Armed with science (and snark), a gynecologist takes on Trump, Goop, and all manner of bizarre health trends

By Meghana Keshavan

Margaret Chan

First Opinion

My decade leading the WHO: dirty fights and steps toward universal coverage

By Margaret Chan

Jennifer Doudna

Heavyweights

CRISPR pioneer Doudna envisions a world of woolly mammoths and unicorns

By Sharon Begley

George Church

Heavyweights

‘A feature, not a bug’: George Church ascribes his visionary ideas to narcolepsy

By Sharon Begley

Andrew Slavitt

Heavyweights

Andy Slavitt can’t stop: How a health care wonk became a rabble-rouser

By Eric Boodman

Henri Termeer

Heavyweights

Henri Termeer, biotech leader who built Genzyme into an industry giant, dies at 71

By Bryan Marquard and Robert Weisman — Boston Globe

Elinore McCance-Katz

Heavyweights

Trump’s pick to run mental health is poised to shake things up. Even some liberals can’t wait

By Meghana Keshavan

Luhan Yang

Heavyweights

She’s hellbent on solving the organ shortage with ‘designer pigs.’ Just don’t keep her waiting

By Sharon Begley

ROIVANT - Group

Heavyweights

One brash idea to save the drug industry — and (maybe) make a few billion dollars

By Damian Garde

Dr. Vivian Lee

Heavyweights

She’s calling for a health care revolution. The radical first step: listen to patients